Cancer Mortality Continues to Decline But Not For Uterine CA

MoeKay

The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported. The news comes from Cancer Statistics, 2020, the latest edition of the American Cancer Society's annual report on cancer rates and trends.

That's the good news.

However, here's the bad news:

• Cancer survival has improved since the mid-1970s for all of the most common cancers except cervical and uterine cancers. Stagnant survival rates for these cancers largely reflect a lack of major treatment advances for patients with recurrent and metastatic disease.

Here's a link to the full Science Daily article which was published today based on newly-released data from the American Cancer Society:

https://www.sciencedaily.com/releases/2020/01/200108074809.htm

 

MoeKay

 

 

 

 

CheeseQueen57

That sucks!

I'm frustrated that uterine cancer is the most common of gynecological cancers but all I read about is ovarian. And just because it's caught early women aren't out of the woods. I just talked to a woman that was stage 1 and reoccurred after 7 years. More research must be done to stop the killing. 

CheeseQueen57

Cervical

And they've almost got this licked with the HPV vaccine. 

MAbound

Stem Cells

I wonder if that's because of the stem cells that TakingControl58 brought up in an earlier thread? Quote below:

I wish to highlight cancer stem cells.  Those are the cells that chemo and radiation don't kill. They are left behind andgo on to form metastases.  So that is something you should focus on since you have a recurrence. There are nocancer drugs that target cancer stem cells, but both metformin and doxycycline both target cancer stem cells.

LisaPizza

MAbound said:

Stem Cells

I wonder if that's because of the stem cells that TakingControl58 brought up in an earlier thread? Quote below:

I wish to highlight cancer stem cells.  Those are the cells that chemo and radiation don't kill. They are left behind andgo on to form metastases.  So that is something you should focus on since you have a recurrence. There are nocancer drugs that target cancer stem cells, but both metformin and doxycycline both target cancer stem cells.

I believe stem cells apply to

I believe stem cells apply to most, if not all, cancers.

Tamlen

Frustrating, yes

When I'm talking to friends about uterine cancer, I always tell them it's the poor cancer cousin, the one no one really bothers with because the cooler cousins always demand all the attention.

NoTimeForCancer

This does suck.  It was all

This does suck.  It was all over the TV on the news, but they don't tell the WHOLE story.  So frustrating.

Mercorby

An Opportunity for us to take action!

Here is one place to support research in this area:  https://www.foundationforwomenscancer.org/support-us/donate/

My doctor will update me about other programs at UCLA, so stay tuned!  We need to get organized!  I have some fundraising ideas.  I just want to make sure we get our $$ to the most effective research programs.

 

 

Forherself

Uterine stem cells

I have an interest in genetics.  I just read a book called Gene.   Sidharta Murkanjee  wrote another about cancer and genes too.  I am going to read it next.  But since stem cells were brought up I thought I would share this link.   You will probably need  to search a few defintions.   But it is interesting for us to read.

https://www.ncbi.nlm.nih.gov/books/NBK27042/

MoeKay

CheeseQueen57 said:

That sucks!

I'm frustrated that uterine cancer is the most common of gynecological cancers but all I read about is ovarian. And just because it's caught early women aren't out of the woods. I just talked to a woman that was stage 1 and reoccurred after 7 years. More research must be done to stop the killing. 

Statistics Tell the Story

Cheese, this year the estimates are that we will lose 12,590 women to uterine cancer and 13,940 to ovarian cancer.  When I was diagnosed in 1999, there were 6,400 deaths annually from uterine cancer.  Perhaps now that the mortality statistics are getting so close between the two cancers, we can hope that the focus will change and more media attention will be given and more research dollars spent on uterine cancer. 

NoTimeForCancer

"Cancer survival has improved

"Cancer survival has improved since the mid-1970s for all of the most common cancers except cervical and uterine cancers. Stagnant survival rates for these cancers largely reflect a lack of major treatment advances for patients with recurrent and metastatic disease."

I have to keep this and use this....